ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
KemPharm Announces FDA Approval of AZSTARYS for ADHD americanpharmaceuticalreview
March 08, 2021KemPharm has announced the U.S. Food and Drug Administration (FDA) has approved the New Drug Application for (NDA) AZSTARYS? (formerly referred to as KP415), a once-daily product for the treatment of attention deficit hyperactivity disorder (ADHD) in ...
Pharma Sources Insight January 2025
